Estrogen-based therapies, including hormone replacement therapy (HRT) and selective estrogen receptor modulators (SERMs), have been widely studied for their potential to alleviate symptoms such as mood swings, anxiety, depression, and cognitive decline [58]. This evidence concerns the gene ESR1 and depressive disorder.